Kimberlee Elizabeth Tafoya, NPC

Kimberlee Tafoya practices at Presbyterian Hospital in Albuquerque, New Mexico, part of Presbyterian Healthcare Services.

Kimberlee Tafoya's NPI, 1235641838, was assigned on November 4, 2017. Kimberlee Tafoya holds New Mexico license CNP-03439.

Kimberlee Tafoya's primary practice is Presbyterian Hospital, at 1100 Central Avenue SE, Albuquerque, NM 87106 in Bernalillo County. The practice phone is (505) 724-8386.

Kimberlee Tafoya's primary practice is Presbyterian Hospital in Albuquerque, New Mexico, part of Presbyterian Healthcare Services. The medical group on file is Presbyterian Medical Group. Dmand AI also links Kimberlee Tafoya to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Kimberlee Tafoya practices, 2 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Kimberlee Tafoya's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Kimberlee Tafoya is licensed in New Mexico.

CMS counts 88 Medicare patients who saw Kimberlee Tafoya in 2024. The largest group is 65 to 74, with 45 patients. 56% of them have high blood pressure, and 55% have high cholesterol. 23% are also on Medicaid. Their average risk score is 0.85, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Kimberlee Tafoya's median patient age at 39, with 73% women.

In 2024, Kimberlee Tafoya wrote 419 Medicare Part D claims for 278 patients. 89% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Kimberlee Tafoya for performance year 2024, reported as part of a group. Kimberlee Tafoya accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Kimberlee Tafoya as offering telehealth.

CMS Open Payments shows 2 general payments to Kimberlee Tafoya from 1 drug or device company in 2025. Speaker and faculty fees make up the largest share, 84% of the total. Abbvie Inc. paid the most, $100.